Mounting evidence for prediagnostic use of statins in reducing risk of lethal prostate cancer

J Clin Oncol. 2014 Jan 1;32(1):1-2. doi: 10.1200/JCO.2013.53.2770. Epub 2013 Nov 25.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / administration & dosage*
  • Male
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / mortality*

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors